Clinical Trials Browser

Advanced Solid Tumour

Advanced Solid Tumour

Mesothelioma, Malignant, Mesothelioma

Malignant Solid Tumor

Mesothelioma, Malignant

Malignant Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumor

Advanced Solid Tumor

Locally Advanced and Metastatic Solid Tumors

Advanced Solid Tumors

Parkinson Disease 4, Autosomal Dominant Lewy Body, Mesothelioma

Unresectable Locally Advanced or Metastatic Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumours

Advanced Solid Tumor

Advanced Solid Tumors

Advanced Solid Tumor

Mesothelioma

Advanced Solid Tumor

Advanced Solid Tumors

Solid Tumors

Advanced Solid Tumor

Mesothelioma, Malignant

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lymphoma, Lymphoma, Non-Hodgkin, Mesothelioma, Neoplasm Metastasis

Mesothelioma, Malignant

Mesothelioma, Malignant, Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

Advanced Solid Tumor

Severe combined immunodeficiency with sensitivity to ionizing radiation, Mesothelioma, Malignant

Mesothelioma

Mesothelioma, Malignant

Solid Tumors

Lung Neoplasms, Mesothelioma, Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung, Mesothelioma, Neoplasms

Advanced Solid Tumors

Mesothelioma, Malignant

Mesothelioma

Clinical Trials

A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

eVOLVE-Meso

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

CheckMate 6DW

A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors

A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors

FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors

MK-3475-A17

Safety and Efficacy of SYHA1813 Single Agent or in Combination With Different Regimens in Unresectable Locally Advanced or Metastatic Solid Tumors.

Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy

Study to Assess the Effects of GS-3583 in Participants With Advanced Solid Tumors

AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer

ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors

HS-20089 Combination Treatment in Subjects With Advanced Solid Tumors

Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors

CheckMate743

Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors

Phase I AZD2281/Cisplatin in Advanced Solid Tumour Patients

A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors

MK-1775-001

R-2

A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors

Amatuximab

A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma

A Study of LY3023414 in Participants With Advanced Cancer

A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor

Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)

A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors

Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma

INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)

M6620 First in Human Study

ARTEMIS

Nintedanib (BIBF 1120) in Mesothelioma

Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR)

Study of NGR-hTNF in Combination With Cisplatin in Solid Tumor

A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies

A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors

Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors

Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma

ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.